POET Technologies Investors Face June 29 Deadline as Class Action Overshadows Lumilens Deal and $400M Raise
25.05.2026 - 14:32:02 | boerse-global.de
A shareholder lawsuit is adding a fresh layer of uncertainty for POET Technologies just as the photonics group tries to turn its biggest commercial breakthrough into revenue. The law firm Faruqi & Faruqi has set a June 29 deadline for investors to step forward and lead the class action, which centres on the abrupt cancellation of all purchase orders from Celestial AI, a former customer now owned by Marvell Semiconductor. Marvell pulled the plug on 23 April, scrapping even the first production units POET had announced only a year earlier. The complaint alleges POET breached confidentiality agreements by disclosing order details and delivery timelines. When the news hit the market on 27 April, the stock plunged more than 45% in a single session.
The legal shock comes on top of first-quarter numbers that underscore how early the company’s commercial ramp remains. Revenue reached $503,389, up from $166,760 a year ago, but fell far short of the $2.2 million analysts had pencilled in. The net loss came in at $12.3 million, or $0.08 per share, leaving little room for error as POET burns through cash to expand its manufacturing footprint.
To fund that expansion, POET raised $400 million in mid-May through a registered direct placement with a single institutional investor. The deal also included 19,047,620 warrants, roughly matching the number of new shares issued. In a clear sign of investor unease, the stock slipped 8.6% in the following week as dilution fears took hold. For a young technology company, fresh capital is essential, but the sheer size of the offering has put pressure on the shares.
Should investors sell immediately? Or is it worth buying POET Technologies?
The strongest pillar of the growth narrative remains the five-year supply agreement with Lumilens, which carries a total potential value of $500 million and includes an initial order worth $50 million. POET expects to ship more than 30,000 optical engines across all its operations this year, with the Lumilens deal’s full contribution likely to appear only in late 2026 or 2027. That timeline puts the company in a delicate spot: the market is pricing in a future that the income statement has yet to confirm.
On the production side, POET is scaling up its facilities in Singapore and Malaysia while bringing in new leadership. Sandeep Kumar has been appointed chief operating officer, and long-time chief financial officer Thomas Mika has announced his retirement. The management shuffle comes as the company tries to deliver on its promises to customers and investors alike.
Beyond the Celestial AI class action, additional lawsuits accuse POET of making misleading statements about its tax status as a passive foreign investment company. The combination of legal risk, equity dilution, and a still-modest revenue base means that every shipment update, liquidity report, or court filing could send the stock swinging. For now, the company’s path to volume sales rests heavily on the Lumilens contract and the efficient deployment of the $400 million it has raised. The June 29 deadline gives affected shareholders a narrow window to decide whether to step into the lead role of the class action, while the rest of the market watches for signs that the photonics story is finally translating into cash flow.
Ad
POET Technologies Stock: New Analysis - 25 May
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
